“As per the discussions that are underway, in all probability the federal government might determine someplace round Rs 300 per dose for the three-shot vaccine,” the identical individual mentioned. The federal government has been shopping for AstraZeneca‘s Covishield and Bharat Biotech’s Covaxin at Rs 157.50 and Rs 225.75 per dose, respectively.
Well being secretary Rajesh Bhushan on Thursday had spoken concerning the pricing. “We’re in dialog with the producer. Since it’s a three-dose vaccine and desires a needle-free injecting system, it’ll have a differential pricing compared to different out there Covid-19 vaccines,” he mentioned.
He additionally confirmed that the Zydus vaccine could be launched very shortly”. The three-dose, needle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the primary Covid-19 vaccine within the nation that has been accredited for the 12 to 18 years age group.